Nicholas Violand

FDA investigator

Appears on 17 documents from 2013 to 2022, mostly at sites in New Jersey. Most often cites control of microbiological contamination (21 CFR 211.113).

17
Documents on file
5.3
Observations per 483
2013
First seen
2022
Most recent

What they cite most

From 93 observations

Activity by year

2013: 2, 2014: 1, 2016: 4, 2017: 3, 2018: 2, 2019: 2, 2021: 1, 2022: 2

Where

New Jersey 11 · India 2 · Maryland 2 · Pennsylvania 1

Is Nicholas Violand coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

17 documents, newest first
FirmOpen
483 Health Pharma USA LLCDec 20, 2022 · Rahway, New Jersey
483 Akorn Operating Company LLC (dba Akorn)May 17, 2022 · Somerset, New Jersey
483 Novitium Pharma LLCJul 8, 2021 · East Windsor, New Jersey
483 KVK-Tech, IncApr 16, 2019 · Newtown, Pennsylvania
483 ONESOURCE SPECIALTY PHARMA LIMITEDFeb 14, 2019 · Bengaluru, India
483 APPCO PHARMA LLCNov 6, 2018 · Piscataway, New Jersey
483 Renaissance Lakewood, LLCMar 15, 2018 · Lakewood, New Jersey

About this profile

What does Nicholas Violand inspect?

Nicholas Violand appears on 17 documents on file covering 15 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nicholas Violand is dated Dec 20, 2022.